SG11201907034PA - Methods of treating influenza - Google Patents
Methods of treating influenzaInfo
- Publication number
- SG11201907034PA SG11201907034PA SG11201907034PA SG11201907034PA SG11201907034PA SG 11201907034P A SG11201907034P A SG 11201907034PA SG 11201907034P A SG11201907034P A SG 11201907034PA SG 11201907034P A SG11201907034P A SG 11201907034PA SG 11201907034P A SG11201907034P A SG 11201907034PA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- sydney
- pct
- level
- new south
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2017900385A AU2017900385A0 (en) | 2017-02-08 | Methods of treating influenza | |
PCT/AU2018/050085 WO2018145148A1 (en) | 2017-02-08 | 2018-02-07 | Methods of treating influenza |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201907034PA true SG11201907034PA (en) | 2019-08-27 |
Family
ID=63106827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201907034PA SG11201907034PA (en) | 2017-02-08 | 2018-02-07 | Methods of treating influenza |
Country Status (13)
Country | Link |
---|---|
US (1) | US10918623B2 (ja) |
EP (1) | EP3579833B1 (ja) |
JP (1) | JP7019727B2 (ja) |
KR (1) | KR102607599B1 (ja) |
CN (1) | CN110325187B (ja) |
AU (1) | AU2018218179B2 (ja) |
BR (1) | BR112019016316A2 (ja) |
CA (1) | CA3052503A1 (ja) |
ES (1) | ES2910136T3 (ja) |
MX (1) | MX2019009443A (ja) |
RU (1) | RU2769317C2 (ja) |
SG (1) | SG11201907034PA (ja) |
WO (1) | WO2018145148A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011280910B2 (en) | 2010-07-22 | 2015-07-09 | Gilead Sciences, Inc. | Methods and compounds for treating Paramyxoviridae virus infections |
TWI698444B (zh) | 2014-10-29 | 2020-07-11 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
PT3785717T (pt) | 2015-09-16 | 2022-04-14 | Gilead Sciences Inc | Métodos para o tratamento de infeções por coronaviridae |
ES2961460T3 (es) | 2017-03-14 | 2024-03-12 | Gilead Sciences Inc | Métodos para tratar las infecciones por coronavirus felinas |
AR111490A1 (es) | 2017-05-01 | 2019-07-17 | Gilead Sciences Inc | Formas cristalinas de propanoato de (s)-2-etilbutil 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino) |
CN111093627B (zh) | 2017-07-11 | 2024-03-08 | 吉利德科学公司 | 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物 |
CA3163424A1 (en) | 2020-01-27 | 2021-08-05 | Gilead Sciences, Inc. | Methods for treating sars cov-2 infections |
AU2021234308C1 (en) | 2020-03-12 | 2024-02-22 | Gilead Sciences, Inc. | Methods of preparing 1'-cyano nucleosides |
CN115362004A (zh) | 2020-04-06 | 2022-11-18 | 吉利德科学公司 | 1’-氰基取代的碳核苷类似物的吸入制剂 |
JP2023528810A (ja) | 2020-05-29 | 2023-07-06 | ギリアード サイエンシーズ, インコーポレイテッド | レムデシビル治療方法 |
EP4172160A2 (en) | 2020-06-24 | 2023-05-03 | Gilead Sciences, Inc. | 1'-cyano nucleoside analogs and uses thereof |
BR112023002951A2 (pt) | 2020-08-24 | 2023-03-21 | Gilead Sciences Inc | Compostos de fosfolipídio e usos destes |
TW202233204A (zh) | 2020-08-27 | 2022-09-01 | 美商基利科學股份有限公司 | 用於治療病毒感染之化合物及方法 |
TWI811812B (zh) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
EP4346772A1 (en) | 2021-05-26 | 2024-04-10 | Gilead Sciences, Inc. | Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs |
CA3228162A1 (en) | 2021-08-18 | 2023-02-23 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
AU2022399231A1 (en) * | 2021-11-24 | 2024-05-23 | Biotron Limited | Methods of treating sars-cov-2 infection |
WO2023167938A1 (en) | 2022-03-02 | 2023-09-07 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
TW202400185A (zh) | 2022-03-02 | 2024-01-01 | 美商基利科學股份有限公司 | 用於治療病毒感染的化合物及方法 |
WO2023168194A1 (en) | 2022-03-03 | 2023-09-07 | Gilead Sciences, Inc. | Antiviral compounds and methods of making and using the same |
WO2023168254A1 (en) | 2022-03-03 | 2023-09-07 | Gilead Sciences, Inc. | Antiviral compounds and methods of making and using the same |
US20240009220A1 (en) | 2022-06-06 | 2024-01-11 | Gilead Sciences, Inc. | Methods for treatment of viral infections |
WO2024006376A1 (en) | 2022-06-29 | 2024-01-04 | Gilead Sciences, Inc. | Solid forms of a nucleoside analogue and uses thereof |
US20240043466A1 (en) | 2022-06-30 | 2024-02-08 | Gilead Sciences, Inc. | Solid forms of a nucleoside analogue and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0612309B8 (pt) | 2005-06-24 | 2021-05-25 | Biotron Ltd | compostos e composições farmacêuticas antivirais |
CN101827589B (zh) * | 2007-08-03 | 2016-08-17 | 拜伊特朗有限公司 | 抗丙型肝炎病毒的组合物及方法 |
KR101369584B1 (ko) * | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
ES2964529T3 (es) * | 2014-07-07 | 2024-04-08 | Elian Llc | Profilaxis anti-VHS preexposición |
CN110870864B (zh) * | 2018-08-29 | 2021-09-24 | 复旦大学 | 马来酸卡比沙明在制备抗流感病毒药物中的应用 |
-
2018
- 2018-02-07 US US16/483,958 patent/US10918623B2/en active Active
- 2018-02-07 AU AU2018218179A patent/AU2018218179B2/en active Active
- 2018-02-07 JP JP2019563650A patent/JP7019727B2/ja active Active
- 2018-02-07 BR BR112019016316-6A patent/BR112019016316A2/pt unknown
- 2018-02-07 KR KR1020197024919A patent/KR102607599B1/ko active IP Right Grant
- 2018-02-07 ES ES18751710T patent/ES2910136T3/es active Active
- 2018-02-07 RU RU2019126746A patent/RU2769317C2/ru active
- 2018-02-07 CA CA3052503A patent/CA3052503A1/en active Pending
- 2018-02-07 CN CN201880010492.9A patent/CN110325187B/zh active Active
- 2018-02-07 MX MX2019009443A patent/MX2019009443A/es unknown
- 2018-02-07 WO PCT/AU2018/050085 patent/WO2018145148A1/en unknown
- 2018-02-07 EP EP18751710.7A patent/EP3579833B1/en active Active
- 2018-02-07 SG SG11201907034PA patent/SG11201907034PA/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3052503A1 (en) | 2018-08-16 |
JP2020506243A (ja) | 2020-02-27 |
KR20190112051A (ko) | 2019-10-02 |
AU2018218179B2 (en) | 2023-05-04 |
AU2018218179A1 (en) | 2019-08-22 |
BR112019016316A2 (pt) | 2020-03-31 |
CN110325187A (zh) | 2019-10-11 |
KR102607599B1 (ko) | 2023-11-28 |
ES2910136T3 (es) | 2022-05-11 |
RU2019126746A3 (ja) | 2021-05-28 |
US20200093796A1 (en) | 2020-03-26 |
EP3579833A4 (en) | 2021-01-13 |
CN110325187B (zh) | 2022-09-30 |
EP3579833B1 (en) | 2022-01-05 |
MX2019009443A (es) | 2019-12-16 |
JP7019727B2 (ja) | 2022-02-15 |
WO2018145148A1 (en) | 2018-08-16 |
RU2019126746A (ru) | 2021-03-09 |
RU2769317C2 (ru) | 2022-03-30 |
US10918623B2 (en) | 2021-02-16 |
EP3579833A1 (en) | 2019-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201907034PA (en) | Methods of treating influenza | |
SG11201906431UA (en) | Method for the treatment of thromboembolism | |
SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
SG11201811470PA (en) | Pyrazolopyrimidine derivatives as kinase inhibitor | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201806868TA (en) | Compositions and methods for protecting against airborne pathogens and irritants | |
SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201407368VA (en) | Drug for preventing and/or treating polycystic kidney disease | |
SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
SG11201810786RA (en) | [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation | |
SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
SG11201906987RA (en) | Combination of a ppar agonist with a fxr agonist | |
SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
SG11201804587QA (en) | Isoindole compounds | |
SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
SG11201901925RA (en) | Methods of treating acute kidney injury | |
SG11201809671PA (en) | Imidazolone compounds as human neutrophil elastase inhibitors | |
SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction | |
SG11201907217RA (en) | Pharmaceutical combinations for treating cancer | |
SG11201810123SA (en) | Treatment of intrahepatic cholestatic diseases | |
SG11201900214UA (en) | Iso-citrate dehydrogenase (idh) inhibitor |